#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Nephrotic syndrome Immune-mediated myasthenia gravis Carcinoid syndrome Cutaneous T-cell lymphoma Diffuse large B-cell lymphoma refractory Osteomyelitis Endometrial adenocarcinoma Homocystinuria Mantle cell lymphoma stage II Fragile X syndrome T-cell lymphoma Congenital pseudarthrosis Breast cancer metastatic Ehlers-Danlos syndrome Gastric cancer More trials…

    Learn about Rare Diseases

    Medulloblastoma – Basic Information Alveolar rhabdomyosarcoma – Basic Information Combined immunodeficiency – Diagnostics Lysosomal storage disorder – Trials in Disease Fragile X syndrome – Diagnostics Nephroblastoma Sarcoma – Trials in Disease Extranodal marginal zone B-cell lymphoma (MALT type) – Treatment Stevens-Johnson syndrome Hereditary ataxia – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Autologous Chondrocytes Fadraciclib MAGNESIUM CARBONATE HEAVY Icosapent Ethyl BRENSOCATIB Pilocarpine Hydrochloride Nanatinostat Tobevibart A24110He Sunvozertinib Metoclopramide Ivermectin Resomelagon Sotorasib Teplizumab Tramadol Ptg-Carcik-Cd19 Clobetasol Propionate Lisaftoclax NORELGESTROMIN More therapies…

    Learn about Your Condition

    Neonatal asphyxia Gender dysphoria Acute lymphocytic leukaemia Habitual abortion Biliary cancer metastatic Phenylketonuria Testis cancer Altered state of consciousness Prinzmetal angina Usher's syndrome Leiomyosarcoma metastatic Rectal neoplasm Pancreatic neoplasm Cutaneous T-cell lymphoma Lung neoplasm malignant More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on Esketamine and Aripiprazole with Antidepressants for Treatment-Resistant Depression in Elderly Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Major depression
    Investigated Drugs:
    • Aripiprazole
    • Esketamine
    Spain

  • Study on Elacestrant and Everolimus for Patients with Advanced ER+/HER2- Breast Cancer Resistant to Endocrine Therapy and CDK4/6 Inhibitors

    Recruiting

    3 1 1
    Investigated Diseases:
    • Hormone receptor positive HER2 negative breast cancer
    Investigated Drugs:
    • Elacestrant
    • Everolimus
    • Betamethasone Sodium Phosphate
    Austria Czechia France Germany Greece Italy +1

  • Antibiotic Treatment with Clindamycin and Benzylpenicillin to Prevent Group G and C Streptococcal Infections in Pregnant Women

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Beta haemolytic streptococcal infection
    Investigated Drugs:
    • Benzylpenicillin Sodium
    • Clindamycin Phosphate
    Finland

  • Esketamine Nasal Spray for Patients with Treatment-Resistant Bipolar Depression

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Bipolar disorder
    Investigated Drugs:
    • Esketamine
    The Netherlands

  • Study of daridorexant and buprenorphine combination treatment for patients with opioid use disorder

    Recruiting

    2 1 1
    Investigated Diseases:
    • Drug use disorder
    Investigated Drugs:
    • Buprenorphine
    • Naloxone
    • Daridorexant
    Sweden

  • Study on the Safety and Effectiveness of Osimertinib and Datopotamab Deruxtecan for Patients with Advanced EGFR Mutation-Positive Non-Small Cell Lung Cancer

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Datopotamab Deruxtecan
    • Osimertinib
    France Germany Italy Poland Spain
Previous Page
1 … 311 312 313 314 315 … 1,649
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!